Recent Press Releases

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

Brings Differentiated, Attractive Product Portfolio and Enhanced Commercial Platform, Diversifying Mylan's Business and Adding New Sales Channels in Acquired Markets

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

Abbott will retain its branded generics pharmaceuticals business in emerging markets

ABBOTT PARK, Ill., Jul

Update re: AbbVie Proposal

14 Jul 2014 Update re: AbbVie Proposal NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE...

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction Brings Differentiated, Attractive Product Portfolio and Enhanced...

New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice

Study Results Presented at the Alzheimer's Association International Conference 2014

INDIANAPOLIS, July 13,

Merck Presents "Premio Letterario Merck" in Rome

• Carlo Rovelli and Francisco Gonzales-Crussi win renowned literature award for "building bridges between literature and science" • Karl-Ludwig Kley: "Through the...

Lilly for Better Health™ expands website's non-product-branded health education resources, focuses on healthy behavior skills

INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly

Abbott Builds Long-Term Commitment in China

ABBOTT PARK, Ill., July 10, 2014 /PRNewswire/ -- Today's announcement of a proposed strategic alliance with Fonterra to develop dairy far

Abbott and Fonterra to Form Strategic Alliance for Dairy Farming in China

First Farm Expected to Produce Milk in First Half of 2017

ABBOTT PARK, Ill.

Vertex Pharmaceuticals Announces Retirement Of Peter Mueller, Ph.D.

Vertex Pharmaceuticals Announces Retirement Of Peter Mueller, Ph.D. Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Peter Mueller, Ph.D., Executive Vice President of Global...

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc.

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc. DEERFIELD, Ill., JULY 7, 2014 - Baxter International Inc. (NYSE:BAX) announced that upon...

Baxter Appoints John Orloff, M.D., Vice President of BioScience R&D

Baxter Appoints John Orloff, M.D., Vice President of BioScience R&D DEERFIELD, Ill., Jul 10, 2014 (BUSINESS WIRE) -- Baxter International Inc. BAX +0.83% today announced the appointment of John...

Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma

Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma 10 July 2014 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the...

Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

INDIANAPOLIS, July 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 (AAIC 2014)

Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc.

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc. DEERFIELD, Ill., JULY 7, 2014 - Baxter International Inc. (NYSE:BAX) announced that upon...

Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology

Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology PR Newswire -8 July 2014 - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM...

NASCAR Driver Ryan Reed Finishes Fourth at the Subway Firecracker 250 at Daytona International Speedway

On and off the track, Reed shows that diabetes doesn't slow him down

INDIANAPOLIS and ALEXANDRIA, Va.